REFERENCES
- Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 1994;14:4368–4374.
- Garcia-Valenzuela E, Gorczyca W, Darzynkiewicz Z, Sharma SC. Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol 1994;25:431–438.
- Barde YA. Trophic factors and neuronal survival. Neuron 1989;2:1525–1534.
- Kermer P, Ankerhold R, Klöcker N, Krajewski S, Reed JC, Bähr M. Caspase-9: involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Brain Res Mol Brain Res 2000;85:144–150.
- Kermer P, Klöcker N, Labes M, Thomsen S, Srinivasan A, Bähr M. Activation of caspase-3 in axotomized rat retinal ganglion cells in vivo. FEBS Lett 1999;453:361–364.
- Isenmann S, Wahl C, Krajewski S, Reed JC, Bähr M. Up-regulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur J Neurosci 1997;9:1763–1772.
- McKernan DP, Cotter TG. A Critical role for Bim in retinal ganglion cell death. J Neurochem 2007;102:922–930.
- Peng PH, Chiou LF, Chao HM et al. Effects of epigallocatechin-3-gallate on rat retinal ganglion cells after optic nerve axotomy. Exp Eye Res 2010;90:528–534.
- Luo JM, Cen LP, Zhang XM et al. PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury. Eur J Neurosci 2007;26:828–842.
- Koeberle PD, Ball AK. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells. Exp Neurol 1999;158:366–381.
- Yoles E, Muller S, Schwartz M. NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush. J Neurotrauma 1997;14:665–675.
- Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997;91:439–442.
- Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197–250.
- Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002;21:1–14.
- Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998;29:2189–2195.
- Siebert H, Dippel N, Mäder M, Weber F, Brück W. Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol 2001;60:85–93.
- Rivera S, Ogier C, Jourquin J et al. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci 2002;15:19–32.
- Fini ME, Parks WC, Rinehart WB et al. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol 1996;149:1287–1302.
- Plantner JJ, Jiang C, Smine A. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 1998;67:637–645.
- Das A, McGuire PG, Eriqat C et al. Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. Invest Ophthalmol Vis Sci 1999;40:809–813.
- Agapova OA, Ricard CS, Salvador-Silva M, Hernandez MR. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 2001;33:205–216.
- Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121–125.
- Zhang X, Sakamoto T, Hata Y et al. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Exp Eye Res 2002;74:577–584.
- Zhang X, Chintala SK. Influence of interleukin-1 β induction and mitogen-activated protein kinase phosphorylation on optic nerve ligation-induced matrix metalloproteinase-9 activation in the retina. Exp Eye Res 2004;78:849–860.
- Zhang X, Cheng M, Chintala SK. Optic nerve ligation leads to astrocyte-associated matrix metalloproteinase-9 induction in the mouse retina. Neurosci Lett 2004;356:140–144.
- Chintala SK, Zhang X, Austin JS, Fini ME. Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem 2002;277:47461–47468.
- Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 2005;46:175–182.
- Mercurio F, Manning AM. Multiple signals converging on NF-κB. Curr Opin Cell Biol 1999;11:226–232.
- Grilli M, Memo M. Possible role of NF-κB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ 1999;6:22–27.
- Choi JS, Sungjoo KY, Joo CK. NF-κ B activation following optic nerve transection. Korean J Ophthalmol 1998;12:19–24.
- Manabe S, Gu Z, Lipton SA. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 2005;46:4747–4753.
- Gasche Y, Soccal PM, Kanemitsu M, Copin JC. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front Biosci 2006;11:1289–1301.
- Azeh I, Mäder M, Smirnov A, Beuche W, Nau R, Weber F. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion. Neurosci Lett 1998;256:127–130.
- Kieseier BC, Clements JM, Pischel HB et al. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome. Ann Neurol 1998;43:427–434.
- Kieseier BC, Seifert T, Giovannoni G, Hartung HP. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology 1999;53:20–25.
- Stüve O, Dooley NP, Uhm JH et al. Interferon β-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 1996;40:853–863.
- Agapova OA, Kaufman PL, Lucarelli MJ, Gabelt BT, Hernandez MR. Differential expression of matrix metalloproteinases in monkey eyes with experimental glaucoma or optic nerve transection. Brain Res 2003;967:132–143.
- Asahi M, Wang X, Mori T et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001;21:7724–7732.
- Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 2002;22:7526–7535.
- Ahmed Z, Dent RG, Leadbeater WE, Smith C, Berry M, Logan A. Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons. Mol Cell Neurosci 2005;28:64–78.
- Yu YM, Lin HC. Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression. Nutr Metab Cardiovasc Dis 2010;20:125–132.
- Rhee JW, Lee KW, Sohn WJ et al. Regulation of matrix metalloproteinase-9 gene expression and cell migration by NF-κ B in response to CpG-oligodeoxynucleotides in RAW 264.7 cells. Mol Immunol 2007;44:1393–1400.
- Grossmann J. Molecular mechanisms of “detachment-induced apoptosis–Anoikis”. Apoptosis 2002;7:247–260.
- Choi JS, Kim JA, Kim DH et al. Failure to activate NF-κB promotes apoptosis of retinal ganglion cells following optic nerve transection. Brain Res 2000;883:60–68.
- Kitaoka Y, Kumai T, Kitaoka Y et al. Nuclear factor-κ B p65 in NMDA-induced retinal neurotoxicity. Brain Res Mol Brain Res 2004;131:8–16.
- Wang J, Jiang S, Kwong JM, Sanchez RN, Sadun AA, Lam TT. Nuclear factor-κB p65 and upregulation of interleukin-6 in retinal ischemia/reperfusion injury in rats. Brain Res 2006;1081:211–218.
- Parodi FE, Mao D, Ennis TL, Bartoli MA, Thompson RW. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-κB. J Vasc Surg 2005;41:479–489.
- Nurmi A, Goldsteins G, Närväinen J et al. Antioxidant pyrrolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxia-ischemia. Free Radic Biol Med 2006;40:1776–1784.
- Ziegler-Heitbrock HW, Sternsdorf T, Liese J et al. Pyrrolidine dithiocarbamate inhibits NF-κ B mobilization and TNF production in human monocytes. J Immunol 1993;151:6986–6993.
- Lewis GP, Erickson PA, Guérin CJ, Anderson DH, Fisher SK. Basic fibroblast growth factor: a potential regulator of proliferation and intermediate filament expression in the retina. J Neurosci 1992;12:3968–3978.
- Brand K, Page S, Rogler G et al. Activated transcription factor nuclear factor-κ B is present in the atherosclerotic lesion. J Clin Invest 1996;97:1715–1722.
- Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996;156:1–4.